Valuation: RAMM Pharma Corp.

Market Cap 597K 427K 381K 352K 319K 40.52M 607K 4.24M 1.68M 21.23M 1.6M 1.57M 66.92M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value -127K -90.47K -80.79K -74.64K -67.64K -8.59M -129K -898K -356K -4.5M -340K -332K -14.19M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
1 day-50.00%
1 month-50.00%
3 months-50.00%
6 months-66.67%
Current year-91.67%
1 week 0
Extreme 0.005
0.01
1 month 0
Extreme 0.005
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.51
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 2019-09-30
Director of Finance/CFO - 2022-12-08
Director TitleAgeSince
Director/Board Member - 2019-09-30
Director/Board Member 82 2019-09-30
Director/Board Member 66 2019-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
6/2/25 Sell

Chief Executive Officer

4,667,000 3.9091%
3/21/25 Buy

Chief Executive Officer

200,000 0.1675%
3/21/25 Buy

Chief Executive Officer

100,000 0.0838%
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%0.00%-50.00%-90.00% 427K
-2.54%+1.31%+54.27%+114.96% 1,135B
-1.42%+3.23%+38.56%+74.44% 635B
+0.16%+0.08%+25.29%+95.23% 505B
-0.31%+3.09%+44.14%+64.80% 378B
-1.34%-0.47%+66.04%+41.00% 358B
-0.68%+2.65%+22.98%+50.39% 295B
-1.20%+3.04%+2.33%+22.86% 266B
-1.79%+1.57%+50.56%+59.08% 237B
-0.73%-0.10%+29.02%+99.67% 193B
Average -5.99%+1.95%+28.32%+53.24% 400.37B
Weighted average by Cap. -1.35%+2.66%+41.02%+79.75%

Financials

2024 2025
Net sales 4.34M 3.1M 2.77M 2.56M 2.32M 295M 4.41M 30.82M 12.2M 154M 11.65M 11.4M 487M 3.36M 2.4M 2.15M 1.98M 1.8M 228M 3.42M 23.85M 9.44M 120M 9.02M 8.83M 377M
Net income -16.5M -11.8M -10.54M -9.73M -8.82M -1.12B -16.78M -117M -46.37M -587M -44.28M -43.34M -1.85B -8.91M -6.37M -5.69M -5.26M -4.76M -605M -9.06M -63.24M -25.04M -317M -23.91M -23.4M -999M
Net Debt -626K -447K -400K -369K -334K -42.47M -636K -4.44M -1.76M -22.25M -1.68M -1.64M -70.15M -723K -517K -462K -427K -387K -49.1M -735K -5.14M -2.03M -25.73M -1.94M -1.9M -81.11M
Projected Income Statement - Annual - RAMM Pharma Corp.
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
26-10-20 $0.005000 -50.00% 27,000
26-10-19 $0.0100 +100.00% 4,000
  1. Stock Market
  2. Stocks
  3. RAMM Stock